Amgen ERISA Case Doesn't Hit Proper Targets: Judge

Law360, New York (March 3, 2010, 1:35 PM EST) -- A judge has dismissed a case brought by employee shareholders against Amgen Inc. over alleged drug safety concerns and illegal marketing that caused the biotechnology company’s stock price to fall, saying the suit does not adequately target the purportedly responsible parties.

Judge Philip S. Gutierrez issued a ruling Tuesday in the U.S. District Court for the Central District of California dismissing most claims and parties in the case, which was brought against Amgen, Amgen Manufacturing Ltd., various directors and officers, and other defendants.

However, the judge...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.